All News

Found 772,975 articles

• Roche Release: Zyvex FDA Advisory Committee Affirms Safety Of Tamiflu In Children

  11/21/2005

• Delcath Systems, Inc. Receives Canadian Patent For Novel Apparatus And Method For Isolated Pelvic Perfusion

  11/21/2005

• Velocity International Announces Patent Application

  11/21/2005

• Carrington Laboratories Announces Closing Of $5.0 Million Private Placement

  11/21/2005

• SemBioSys Genetics Inc. Executes $2,500,000 Debt Financing Agreement

  11/21/2005

• Varian Medical Systems' Board Of Directors Authorizes Repurchase Of Another Six Million Shares Of Stock

  11/21/2005

• Orgenics Announces Financing Commitment

  11/21/2005

• MacroChem Corporation Delisted From Quotation On Nasdaq Capital Market

  11/21/2005

• Sirna Therapeutics, Inc. To Join The NASDAQ Biotechnology Index

  11/21/2005

• Aksys Receives NASDAQ Notification

  11/21/2005

• Aksys Announces Implementation Of More Focused Strategy

  11/21/2005

• Scott+Scott, LLC: A Leader In Pharmaceutical Corp Securities Fraud Litigation Filed Initial Case Against Boston Scientific Corporation On September 21, 2005; $400 Million In Insider Trading Alleged

  11/21/2005

• Shareholder Lawsuit Filed Against Guidant Corporation, Berman DeValerio Pease Tabacco Burt & Pucillo Says

  11/21/2005

• R2 Technology, Inc. Launches Version 8.1 Mammography CAD System For Maximum Flexibility And Detection Performance

  11/21/2005

• Bayer Healthcare, Diagnostics (Tarrytown, NY) Launches ADVIA Centaur(R) CP Immunoassay System

  11/21/2005

• Introduction Of Identa Corporation's Methamphetamine Detector A Big Success At CNOA Conference

  11/21/2005

• KineMed, Inc. Presents Body Water Test As A Potential New 'Gold Standard' For Measuring Insulin Resistance At The 3rd Annual World Congress On The Insulin Resistance Syndrome

  11/21/2005

• BioMimetic Therapeutics Announces FDA Approval Of GEM 21S(R) Growth-Factor Enhanced Matrix For The Treatment Of Periodontally-Related Bone Defects

  11/21/2005

• X-Cell Medical, Inc. Completes Enrollment For Clinical Trial Of ETHOS I Estradiol Eluting Stent

  11/21/2005

• Valera Pharmaceuticals Receives Marketing Authorization In Denmark For VANTAS

  11/21/2005